On April 18, 2024, Entheon Biomedical Corp. closed the transaction. All securities issued under the placement are subject to a hold period of four months and one day expiring on Aug.
19, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.165 CAD | -23.26% | -23.26% | +65.00% |
04-29 | Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
04-18 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
On April 18, 2024, Entheon Biomedical Corp. closed the transaction. All securities issued under the placement are subject to a hold period of four months and one day expiring on Aug.
19, 2024.
1st Jan change | Capi. | |
---|---|---|
+65.00% | 1.07M | |
+22.49% | 44.96B | |
+0.80% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+11.14% | 26.08B | |
-21.44% | 19.03B | |
+6.05% | 12.75B | |
+28.87% | 12.06B | |
-3.52% | 11.75B |